BioLife Solutions (BLFS) has entered into a 10-year agreement with Bellicum Pharmaceuticals (BLCM) o supply its CryoStor clinical grade freeze media. The product will be incorporated into the manufacturing of certain Bellicum cellular immunotherapies. Financial terms of the deal have not been disclosed.